BACKGROUND: Proximal femoral fracture often occurs in elderly population, and selecting the appropriate fixation implants is the key to guarantee the biocompatibility and treatment effect.
OBJECTIVE: To analyze the selection and the biocompatibility of the metal implants for internal fixation for the treatment of proximal femoral fracture.
METHODS: The relative databases at home and abroad were searched by the first author for the relative articles in December 2012. The Chinese key words were “proximal femoral fracture, dynamic hip screw, less invasive stabilization system, percutaneous compression plate, Gamma nail, intramedullary nail”, and the English key words were “proximal femoral fracture, dynamic hip screw, less invasive stabilization system, percutaneous compression plate, Gamma nail”. The literatures of the articles were Chinese and English. A total of 142 articles were screened out, and 17 articles were included for the final analysis according to the inclusion criteria.
RESULTS AND CONCLUSION: The methods for the treatment of proximal femoral fracture included conservative treatment, metal implants internal fixation, external fixation, locking plate and prosthesis replacement therapy. At present, the domestic and international treatment points have abandoned the conservative treatments such as traction, and try best to perform the metal implants internal fixation. The clinical metal implants internal fixation can be divided into extramedullary fixation device and intramedullary fixation device, and the extramedullary fixation device included dynamic hip screw, inverted distal femoral less invasive stabilization system and percutaneous compression plate, while the intramedullary fixation device included the proximal femoral intramedullary nail, Gamma nail and reconstruction nail. Each treatment method and internal fixation device has their own advantages and limitations. We should propose a personalized treatment program and select the appropriate method according to the patient’s condition and treatment requirement during the clinical treatment.